JPRN-UMIN000039230已完成未知
Phase II study of 1st-line biweekly Gemcitabine and Carboplatin vs biweekly Gemcitabine and Carboplatin plus maintenance Gemcitabine in elderly patient untreated non-small cell lung cancer - LOGIK0801
Clinical Research Support Center Kyushu0 个研究点目标入组 83 人开始时间: 2020年1月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 83
研究概览
简要总结
mPFS(95%CI) control 4.99mo(3.29-6.28) maintenance 4.44mo(2.86-6.34) (p=0.47 log-rank)
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients with obvious infections (2) Patients with fever (38C or higher) (3) Serious complications (heart disease, pulmonary fibrosis/interstitial pneumonia, bleeding tendency, uncontrolled) Patients with hypertension, diabetes mellitus, etc. (4) Patients with active double cancer (disease-free interval <5 years) (5) Symptomatic patients with brain metastases (6) Patients with pleural effusions and ascites requiring treatment (7) Patients with pericardial effusion (8) Patients with varicella (9) Patients with motor paralysis or peripheral nerve symptoms (excluding those originating from the primary disease) (10) Patients with a history of drug hypersensitivity (11) Pregnant, breastfeeding, and women of childbearing potential (willingness) (12) Other patients judged inappropriate by the investigator
研究者
相似试验
已完成
2 期
A combination phase II study of gemcitabine and S-1 for platinum-refractory patients with non-small cell lung cancer (TORG 0705)on-small cell lung cancerJPRN-UMIN000000896Thoracic Oncology Research Group32
招募中
2 期
Phase II study of Gemcitabine plus alternate-day administrations of S-1 in patients with unresectable advanced pancreatic cancer.pancreatic cancerJPRN-UMIN000010088Fukushima medical University Hospital, School of medicine30
已完成
2 期
Phase 2 study of fix dose rate gemcitabine plus S-1 with advanced biliary tract cancer refractory to standard dose rate gemcitabineJPRN-UMIN000005918Yokohama Clinical Oncology Group40
已完成
2 期
A phase II trial of gemcitabine in a fixed dose rate infusion combined with cisplatin in patients with operable biliary tract carcinomasAdenocarcinoma of the gallbladder or intra/extrahepatic bile ductsCancer - Biliary tree (gall bladder and bile duct)ACTRN12605000001695AGITG/ NHMRC Clinical Trials Centre45
已完成
2 期
A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast CancerBreast CancerNCT00191347Eli Lilly and Company30